Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369067 · ClinicalTrials.gov registry record · NA
Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03369067 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 48 participants.
The verdict
NCT03369067, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
An early feasibility study that will test the efficacy of the Tandem t:slim X2 with Control-IQ and Dexcom Continuous Glucose System G6 in a winter/ski camp environment.
Interventions
- DEVICE Tandem t:slim X2 with Control-IQ Technology + Dexcom G6
- DEVICE Dexcom CGM G5
- DEVICE Continuous Subcutaneous Insulin Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2018-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03369067
The ClinicalTrials.gov registry entry for NCT03369067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 is the first listed.
NCT03369067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03369067 about?
NCT03369067 is a clinical study titled "Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp". An early feasibility study that will test the efficacy of the Tandem t:slim X2 with Control-IQ and Dexcom Continuous Glucose System G6 in a winter/ski camp environment.
What is the current status of trial NCT03369067?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2017-12-18. Estimated completion is 2018-04-15.
What interventions are being tested in trial NCT03369067?
The interventions under investigation include: Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 (DEVICE), Dexcom CGM G5 (DEVICE), Continuous Subcutaneous Insulin Infusion (DEVICE).
Who is sponsoring clinical trial NCT03369067?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.